Tirzepatide achieved 22.5% in 72 weeks
Do not wait for routine labs Fever, bloody stool, severe abdominal pain, spreading rash, jaundice, allergic symptoms, or severe wound changes need medical review
However, comprehensive long-term safety data remains limited, particularly regarding extended use over months or years
Please follow your physician's mixing and dosing instructions if they differ from the ones we have listed above
This meeting was different: instead of forming a committee to review our claims from the outside, they did the sensible thing
Brazilian Journal of Microbiology, 41(3): 635642 Matafonova G, Batoev V (2012)